Respiratory cryptosporidiosis in Malawian children with diarrheal disease.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
07 2021
Historique:
received: 07 05 2021
accepted: 11 07 2021
revised: 11 08 2021
pubmed: 31 7 2021
medline: 25 2 2023
entrez: 30 7 2021
Statut: epublish

Résumé

Respiratory cryptosporidiosis has been documented in children with diarrhea. We sought to describe the dynamics of respiratory involvement in children hospitalized with gastrointestinal (GI) diarrheal disease. We conducted a prospective, observational longitudinal study of Malawian children 2-24 months hospitalized with diarrhea. Nasopharyngeal (NP) swabs, induced sputum and stool specimens were collected. Participants that were positive by Cryptosporidium PCR in any of the three compartments were followed up with fortnightly visits up to 8 weeks post-enrollment. Of the 162 children recruited, participants had mild-moderate malnutrition (mean HAZ -1.6 (SD 2.1)), 37 (21%) were PCR-positive for Cryptosporidium at enrollment (37 stool, 11 sputum, and 4 NP) and 27 completed the majority of follow-up visits (73%). Cryptosporidium was detected in all compartments over the 4 post-enrollment visits, most commonly in stool (100% at enrollment with mean cycle thresholds (Ct) of 28.8±4.3 to 44% at 8 weeks with Ct 29.9±4.1), followed by sputum (31% at enrollment with mean Ct 31.1±4.4 to 20% at 8 weeks with Ct 35.7±2.6), then NP (11% with mean Ct 33.5±1.0 to 8% with Ct 36.6±0.7). Participants with Cryptosporidium detection in both the respiratory and GI tract over the study period reported respiratory and GI symptoms in 81% and 62% of study visits, respectively, compared to 68% and 27%, respectively, for those with only GI detection, and had longer GI shedding (17.5±6.6 v. 15.9±2.9 days). Cryptosporidium was detected in both respiratory and GI tracts throughout the 8 weeks post-enrollment. The development of therapeutics for Cryptosporidium in children should target the respiratory as well as GI tract.

Sections du résumé

BACKGROUND
Respiratory cryptosporidiosis has been documented in children with diarrhea. We sought to describe the dynamics of respiratory involvement in children hospitalized with gastrointestinal (GI) diarrheal disease.
METHODS
We conducted a prospective, observational longitudinal study of Malawian children 2-24 months hospitalized with diarrhea. Nasopharyngeal (NP) swabs, induced sputum and stool specimens were collected. Participants that were positive by Cryptosporidium PCR in any of the three compartments were followed up with fortnightly visits up to 8 weeks post-enrollment.
RESULTS
Of the 162 children recruited, participants had mild-moderate malnutrition (mean HAZ -1.6 (SD 2.1)), 37 (21%) were PCR-positive for Cryptosporidium at enrollment (37 stool, 11 sputum, and 4 NP) and 27 completed the majority of follow-up visits (73%). Cryptosporidium was detected in all compartments over the 4 post-enrollment visits, most commonly in stool (100% at enrollment with mean cycle thresholds (Ct) of 28.8±4.3 to 44% at 8 weeks with Ct 29.9±4.1), followed by sputum (31% at enrollment with mean Ct 31.1±4.4 to 20% at 8 weeks with Ct 35.7±2.6), then NP (11% with mean Ct 33.5±1.0 to 8% with Ct 36.6±0.7). Participants with Cryptosporidium detection in both the respiratory and GI tract over the study period reported respiratory and GI symptoms in 81% and 62% of study visits, respectively, compared to 68% and 27%, respectively, for those with only GI detection, and had longer GI shedding (17.5±6.6 v. 15.9±2.9 days).
CONCLUSION
Cryptosporidium was detected in both respiratory and GI tracts throughout the 8 weeks post-enrollment. The development of therapeutics for Cryptosporidium in children should target the respiratory as well as GI tract.

Identifiants

pubmed: 34329296
doi: 10.1371/journal.pntd.0009643
pii: PNTD-D-21-00656
pmc: PMC8357119
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009643

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: PI has received grants from BMGF outside of the submitted work. All other authors have declared that no competing interests exist.

Références

BMC Infect Dis. 2019 Aug 19;19(1):728
pubmed: 31426759
J Med Microbiol. 2006 Sep;55(Pt 9):1217-1222
pubmed: 16914651
PLoS Negl Trop Dis. 2015 Oct 08;9(10):e0003987
pubmed: 26447884
Clin Microbiol Rev. 2017 Oct;30(4):919-971
pubmed: 28768707
Lancet Infect Dis. 2015 Jan;15(1):85-94
pubmed: 25278220
Clin Infect Dis. 2012 Apr;54 Suppl 2:S140-5
pubmed: 22403228
J Infect Dis. 2000 May;181(5):1643-51
pubmed: 10823764
Clin Infect Dis. 2018 Nov 13;67(11):1660-1669
pubmed: 29701852
Pediatr Infect Dis J. 2019 Aug;38(8):e175-e177
pubmed: 31306401
Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):677-81
pubmed: 8565984
Lancet Glob Health. 2015 Sep;3(9):e564-75
pubmed: 26202075
Lancet Infect Dis. 2014 Aug;14(8):716-724
pubmed: 25022434
BMJ. 1993 Aug 14;307(6901):417-20
pubmed: 8374453
J Eukaryot Microbiol. 1996 Sep-Oct;43(5):78S-79S
pubmed: 8822872
Front Immunol. 2019 Jul 29;10:1728
pubmed: 31417545
J Clin Microbiol. 1996 Jan;34(1):227-9
pubmed: 8748314
PLoS Negl Trop Dis. 2016 May 04;10(5):e0004564
pubmed: 27144404
Nature. 2013 Nov 14;503(7475):189-91
pubmed: 24236315
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Clin Infect Dis. 2010 May 15;50(10):1366-72
pubmed: 20377408
Clin Infect Dis. 2019 Mar 19;68(7):1073-1079
pubmed: 30192924
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
Clin Infect Dis. 2021 Jul 15;73(2):183-191
pubmed: 32277809
Clin Infect Dis. 2015 Oct 15;61(8):1217-24
pubmed: 26245665
Lancet. 2002 Feb 16;359(9306):564-71
pubmed: 11867110
Infection. 1996 Sep-Oct;24(5):341-6
pubmed: 8923043
Clin Microbiol Rev. 2014 Jul;27(3):575-86
pubmed: 24982322
J Infect Dis. 2019 Jun 19;220(2):213-218
pubmed: 30816414
Emerg Infect Dis. 2007 Mar;13(3):462-4
pubmed: 17552101
J Pediatr Gastroenterol Nutr. 1984;3(1):149-57
pubmed: 6694044
J Parasitol. 2011 Dec;97(6):1113-20
pubmed: 21711105
Lancet. 1988 Mar 12;1(8585):590-1
pubmed: 2894523

Auteurs

Pui-Ying Iroh Tam (PY)

Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Department of Paediatrics, University of Malawi College of Medicine, Blantyre, Malawi.
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Mphatso Chisala (M)

Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Wongani Nyangulu (W)

Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Herbert Thole (H)

Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

James Nyirenda (J)

Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH